Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Tavist offering

This article was originally published in The Tan Sheet

Executive Summary

Novartis Tavist NightTime Allergy provides "relief from sinus & nasal congestion, runny nose & sneezing" with an antihistamine "so you can rest," product labeling says. Line extension, which began hitting shelves in March, contains diphenhydramine 25 mg as an antihistamine, pseudoephedrine 60 mg as a nasal decongestant and is the only OTC positioned primarily for relief of nighttime allergy symptoms, Novartis says. Available in 24- and 48-count caplets for between $3.99 and $6.99, NightTime Allergy is the Tavist line's fourth offering. Product, which was originally named Tavist D/A, was slated to debut a year ago (1"The Tan Sheet" March 5, 2001, p. 5)...
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS093921

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel